Literature DB >> 18080753

Age- and sex-dependent differential interaction of nuclear trans-acting factors with Fmr-1 promoter in mice brain.

S Prasad1, Kanchan Singh.   

Abstract

We have investigated relation between interaction of the trans-acting factors with Fmr-1 promoter and expression of FMRP isoforms in intact mouse brain as a function of age and sex. Our EMSA data reveal that among the three complexes formed with 136 bp Fmr-1 promoter fragment, the level of complex C1 significantly increases in adult brain but decreases in old brain in comparison to that in young. The level of total FMRP significantly decreases from young to old in the brain of both the sexes, however, among the three isoforms, expression of the 80-kDa isoform significantly decreases in the brain of both the sexes where as the level of 70 kDa isoform decreases in females during aging. The present finding on relation between age- and sex-dependent interaction of trans-acting factors and expression of FMRP isoforms is novel and may be relevant for regulation of Fmr-1 gene in brain function during aging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080753     DOI: 10.1007/s11064-007-9545-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  52 in total

1.  Analysis of neocortex in three males with the fragile X syndrome.

Authors:  V J Hinton; W T Brown; K Wisniewski; R D Rudelli
Journal:  Am J Med Genet       Date:  1991-12-01

Review 2.  Synaptic regulation of protein synthesis and the fragile X protein.

Authors:  W T Greenough; A Y Klintsova; S A Irwin; R Galvez; K E Bates; I J Weiler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Differential translation and fragile X syndrome.

Authors:  P W Vanderklish; G M Edelman
Journal:  Genes Brain Behav       Date:  2005-08       Impact factor: 3.449

5.  A nuclear role for the Fragile X mental retardation protein.

Authors:  R A Fridell; R E Benson; J Hua; H P Bogerd; B R Cullen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.

Authors:  M Abitbol; C Menini; A L Delezoide; T Rhyner; M Vekemans; J Mallet
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

Review 7.  Regulating fragile X gene transcription in the brain and beyond.

Authors:  Jae H Lim; Anne B Booker; Justin R Fallon
Journal:  J Cell Physiol       Date:  2005-11       Impact factor: 6.384

8.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

9.  The pre-mRNA binding K protein contains a novel evolutionarily conserved motif.

Authors:  H Siomi; M J Matunis; W M Michael; G Dreyfuss
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

10.  The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter.

Authors:  Daman Kumari; Andrei Gabrielian; David Wheeler; Karen Usdin
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

View more
  2 in total

1.  Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.

Authors:  Daman Kumari; Aditi Bhattacharya; Jeffrey Nadel; Kristen Moulton; Nicole M Zeak; Anne Glicksman; Carl Dobkin; David J Brick; Philip H Schwartz; Carolyn B Smith; Eric Klann; Karen Usdin
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

2.  FMRP S499 is phosphorylated independent of mTORC1-S6K1 activity.

Authors:  Christopher M Bartley; Rachel A O'Keefe; Angélique Bordey
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.